Salivary Cystatin S Levels in a Group of Egyptian Children

计划入组 30 人 · 首次发布于 2023 年 2 月 8 日

Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care

计划入组 416 人 · 首次发布于 2021 年 4 月 9 日

Women s Health Awareness Community Resiliency, Environmental Action and Collaborations for Health (REACH) Equity

计划入组 700 人 · 首次发布于 2021 年 7 月 30 日

Streptococcus A Group（Luya Pharma）

Irinotecan hydrochloride liposomal (Luye Pharma Group)

ZP-3022(Zealand Pharma A/S)

CELON PHARMA S A

Poland

Glaxosmithkline Pharma A/S

Denmark

Zealand Pharma A/S

Denmark

Reponex Pharmaceuticals Secures European Patent for Inflammatory Bowel Disease Treatment Targeting $4.7 Billion Market

Reponex Pharmaceuticals Prioritizes Clinical Programs for Colon Cancer, Peritonitis, and IBD

Pharma Equity Group Receives Regulatory Approval for Phase II Trial of RNX-011 in Secondary Peritonitis